Antibodies against amyloid beta protein deposits that are thought to play a role in Alzheimer’s disease have shown some success in preventing the buildup of deposits in animals, but they have not been effective at removing preexisting deposits. Now researchers show that a modified antibody was able to clear preexisting amyloid beta deposits in a mouse model of Alzheimer’s disease.